Adverse effect of ganglionic blocking drugs, subs encntr

This code signifies a patient experiencing an unintended and harmful reaction to a ganglionic blocking drug, such as those used to treat hypertension or autonomic dysfunction, during a follow-up visit. The adverse effect is not due to poisoning or overdose, but rather an expected or unexpected side effect of the medication when administered correctly.

Apply this code when a patient presents for ongoing management or evaluation of an adverse effect from a ganglionic blocking agent, after the initial treatment for the adverse effect has been rendered. This includes situations where the patient is being monitored for resolution of symptoms or adjusting their medication regimen due to the adverse reaction.

• Always sequence this code after the code describing the specific adverse effect experienced by the patient.
• Ensure documentation clearly indicates the encounter is for follow-up care related to the adverse effect, not the initial treatment.
• Verify the medication involved is indeed a ganglionic blocking drug to ensure accurate code selection.